Emergency Use Authorization (EUA)
-
LumiraDx receives CDSCO approval for COVID-19 antigen test use in India
LumiraDx’s microfluidic technology and innovative POC Platform supports a broad menu of tests with lab-comparable performance, at a low cost,…
Read More » -
Zydus receives EUA from DCGI for needle-free COVID vaccine ZyCoV-D
World’s first Plasmid DNA Vaccine for COVID-19, ZyCoV-D will be administered in three doses Zydus Cadila has received the Emergency…
Read More » -
Zydus applies to DCGI for EUA to launch ZyCoV-D
Presents interim results from Phase III clinical trials in over 28,000 volunteers Zydus Cadila has applied for Emergency Use Authorization…
Read More »